It will be interesting to see if the all-in production cost goes up a bit in future reports.The board members seem to be a very capable and experienced bunch so I expect they can handle it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025